- Shares of nano cap Aastrom Biosciences (ASTM +25.4%) roar ahead on a 12x surge in volume. Today's bullish action follows yesterday's 24% up move.
- Market chatter says that the firm will report good news from its phase 2 clinical trial of ixmyelocel-T at the upcoming Regen Med Investor Day on March 26 in Ann Arbor, MI.
- The company's market cap is only $25M. Average daily turnover is a modest 200K shares. Investors should be cautious here.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs